Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “End-of-Life”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05372510
What this trial is testing

Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

Who this might be right for
Acute Human Immunodeficiency Virus Type I Infection
MRC/UVRI and LSHTM Uganda Research Unit 100
Not applicableStudy completedNCT00234286
What this trial is testing

Intervention to Improve Care at Life's End

Who this might be right for
DeathPainDyspnea
US Department of Veterans Affairs 78
Early research (Phase 1)Study completedNCT00168688
What this trial is testing

Prenatal Multi-micronutrient Supplementation and Pregnancy Outcome

Who this might be right for
PregnancyBirth Weight
Bandim Health Project 2,100
Not applicableUnknownNCT05823051
What this trial is testing

The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study

Who this might be right for
Sudden Infant Death
Dilara Aydin Tozlu 80
Testing effectiveness (Phase 2)Study completedNCT02495077
What this trial is testing

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

Who this might be right for
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 290
Testing effectiveness (Phase 2)Study completedNCT04700072
What this trial is testing

Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Not applicableUnknownNCT05895669
What this trial is testing

Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)

Who this might be right for
Liver Transplant; ComplicationsCardiovascular ComplicationCardiovascular; Attack+2 more
University of Campania Luigi Vanvitelli 100
Not applicableStudy completedNCT00760201
What this trial is testing

Qualitative Analysis of Hospital Executives, Physician Administrators, and Hospital Legal Counsels' Perceptions of End-of-Life Care

Who this might be right for
End of Life Care
US Department of Veterans Affairs 14
Not applicableStudy completedNCT04627012
What this trial is testing

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAnti-PD1 AntibodyLiver Diseases
Sun Yat-sen University 600
Not applicableUnknownNCT00826319
What this trial is testing

Canadian Study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular Events Over Time

Who this might be right for
Chronic Kidney Disease
University of British Columbia 2,602
Not applicableUnknownNCT04837612
What this trial is testing

Observational Study for Patients With Dilated Cardiomyopathy

Who this might be right for
DCM - Dilated Cardiomyopathy
Guangdong Provincial People's Hospital 500
Not applicableStudy completedNCT04690205
What this trial is testing

Hospital at Home at EOL in Heme Malignancies

Who this might be right for
Hematologic Malignancy
Massachusetts General Hospital 72
Not applicableLooking for participantsNCT07020702
What this trial is testing

ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction

Who this might be right for
Ventricular ArrhythmiaCardiomyopathiesLeft Ventricular Ejection Fraction Less Then or Equal to 50percent
University Hospital, Bordeaux 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT05709574
What this trial is testing

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
University of Arizona 11
Large-scale testing (Phase 3)Study completedNCT05064059
What this trial is testing

Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

Who this might be right for
Colorectal Cancer
Merck Sharp & Dohme LLC 441
Not applicableStudy completedNCT02001480
What this trial is testing

Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease

Who this might be right for
Diabetes Mellitus Type 2End Stage Renal Disease
RWTH Aachen University 60
Not applicableStudy completedNCT00339976
What this trial is testing

Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
National Institute of Environmental Health Sciences (NIEHS)
Not applicableUnknownNCT03458052
What this trial is testing

Organ Donation Survey Among Health Care Professionals in Argentina

Who this might be right for
Brain DeathLung TransplantationRespiration, Artificial+1 more
Hospital Italiano de Buenos Aires 200
Not applicableStudy completedNCT03699748
What this trial is testing

Lay Health Worker Engage, Educate, and Encourage Patients to Share

Who this might be right for
End of LifeCancer
Stanford University 160
Next Page